GE Healthcare announced this week that it would be teaming up with the American College of Cardiology to push forward artificial intelligence and digital technology in cardiac care.
The company says it will lend its perspective to the ACC s Applied Health Innovation Consortium, a collaboration of patient advocates and academic, clinical, industry and technology partners aimed at digitally transforming healthcare. We are excited to have GE Healthcare join forces with the Applied Health Innovation Consortium, said Dr. John Rumsfeld, ACC chief innovation officer and chief science and quality officer, in a statement. In our mission to transform cardiovascular care and improve heart health, GE Healthcare is a great collaborator to help build a roadmap for AI and digital technology that bridges gaps in clinical care, added Rumsfeld.
COVID-19 Vaccine Provider Alert Important Update and Resources Regarding Myocarditis and Pericarditis Wednesday, June 2, 2021
The Michigan Department of Health and Human Services (MDHHS) has received additional guidance from the Centers for Disease Control and Prevention (CDC) regarding myocarditis and pericarditis to share with providers. Since April 2021, increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna). CDC is aware of these reports, which are rare given the number of vaccine doses administered. CDC and its partners are actively monitoring these reports, by reviewing data and medical records, to learn more about what happened and to see if there is any relationship to COVID-19 vaccination. Cases reported to VAERS have occurred mostly in male adolescents and young adults aged 16 years or older. These cases have been seen more often after getting the second dose than th
Dallas [US], June 2 (ANI): While a lot of people are suffering from elevated blood pressure and blood cholesterol, a recent study has pointed out a common first treatment choice prescribed by medical practitioners.
American Heart Association
Statement Highlights:
Physical activity is the optimal first treatment choice for adults with mild to moderately elevated blood pressure and blood cholesterol who otherwise have low heart disease risk.
About 21% of adults in the U.S. with mild to moderately raised blood pressure and 28-37% of those with mild to moderate elevated cholesterol levels may be best served by a prescription for lifestyle-only treatment, which includes increasing physical activity.
Doctors can promote physical activity with their patients by asking them about activity levels at every visit, as well as providing resources and referrals to help them begin and continue regular physical activity.